Pure Bioscience OTC Stock Forecast - Simple Moving Average
| PURE Stock | USD 0.05 0.01 25.00% |
The Simple Moving Average forecasted value of Pure Bioscience on the next trading day is expected to be 0.05 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.14. Pure OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Pure Bioscience stock prices and determine the direction of Pure Bioscience's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pure Bioscience's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the value of rsi of Pure Bioscience's share price is below 20 indicating that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pure Bioscience based on different types of headlines from major news networks to social media. Using Pure Bioscience hype-based prediction, you can estimate the value of Pure Bioscience from the perspective of Pure Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Pure Bioscience on the next trading day is expected to be 0.05 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.14. Pure Bioscience after-hype prediction price | USD 0.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pure |
Pure Bioscience Additional Predictive Modules
Most predictive techniques to examine Pure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pure using various technical indicators. When you analyze Pure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Pure Bioscience Simple Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Pure Bioscience on the next trading day is expected to be 0.05 with a mean absolute deviation of 0, mean absolute percentage error of 0.000018, and the sum of the absolute errors of 0.14.Please note that although there have been many attempts to predict Pure OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pure Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Pure Bioscience OTC Stock Forecast Pattern
| Backtest Pure Bioscience | Pure Bioscience Price Prediction | Buy or Sell Advice |
Pure Bioscience Forecasted Value
In the context of forecasting Pure Bioscience's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Pure Bioscience's downside and upside margins for the forecasting period are 0.0005 and 8.35, respectively. We have considered Pure Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Pure Bioscience otc stock data series using in forecasting. Note that when a statistical model is used to represent Pure Bioscience otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.5268 |
| Bias | Arithmetic mean of the errors | 8.0E-4 |
| MAD | Mean absolute deviation | 0.0024 |
| MAPE | Mean absolute percentage error | 0.0458 |
| SAE | Sum of the absolute errors | 0.1388 |
Predictive Modules for Pure Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pure Bioscience. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pure Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Pure Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pure Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Pure Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pure Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Pure Bioscience's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pure Bioscience's historical news coverage. Pure Bioscience's after-hype downside and upside margins for the prediction period are 0.00 and 8.35, respectively. We have considered Pure Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pure Bioscience is out of control at this time. Analysis and calculation of next after-hype price of Pure Bioscience is based on 3 months time horizon.
Pure Bioscience OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Pure Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pure Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pure Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.44 | 8.30 | 0.00 | 0.01 | 0 Events / Month | 3 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.05 | 0.05 | 0.00 |
|
Pure Bioscience Hype Timeline
Pure Bioscience is at this time traded for 0.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Pure is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.44%. %. The volatility of related hype on Pure Bioscience is about 46111.11%, with the expected price after the next announcement by competition of 0.06. About 41.0% of the company outstanding shares are owned by corporate insiders. The book value of Pure Bioscience was at this time reported as 0.03. The company recorded a loss per share of 0.04. Pure Bioscience had not issued any dividends in recent years. The entity had 1:8 split on the 15th of August 2012. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Historical Fundamental Analysis of Pure Bioscience to cross-verify your projections.Pure Bioscience Related Hype Analysis
Having access to credible news sources related to Pure Bioscience's direct competition is more important than ever and may enhance your ability to predict Pure Bioscience's future price movements. Getting to know how Pure Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pure Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EXDW | Exceed World | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | 0.00 | 32.00 | |
| TNYBF | The Tinley Beverage | 0.06 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HERB | Yasheng Group | 0.00 | 0 per month | 15.65 | 0.13 | 70.91 | (36.60) | 123.64 | |
| DQWS | DSwiss Inc | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 42.39 | |
| INDFY | Indofood Agri Resources | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 18.39 | |
| NPRFF | Nepra Foods | 0.06 | 4 per month | 10.08 | 0.02 | 23.61 | (20.09) | 71.45 | |
| CAWW | CCA Industries | 0.00 | 0 per month | 0.00 | (0.12) | 4.35 | (5.71) | 18.77 | |
| NUVI | Emo Capital Corp | 0.06 | 8 per month | 0.00 | 0.08 | 0.00 | 0.00 | 199.43 | |
| LNLHF | LeanLife Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HIGR | Hi Great Group Holding | 0.00 | 0 per month | 20.98 | 0.19 | 98.02 | (73.87) | 531.82 |
Other Forecasting Options for Pure Bioscience
For every potential investor in Pure, whether a beginner or expert, Pure Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pure OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pure. Basic forecasting techniques help filter out the noise by identifying Pure Bioscience's price trends.Pure Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pure Bioscience otc stock to make a market-neutral strategy. Peer analysis of Pure Bioscience could also be used in its relative valuation, which is a method of valuing Pure Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pure Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Pure Bioscience otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pure Bioscience shares will generate the highest return on investment. By undertsting and applying Pure Bioscience otc stock market strength indicators, traders can identify Pure Bioscience entry and exit signals to maximize returns.
Pure Bioscience Risk Indicators
The analysis of Pure Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pure Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pure otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.61 | |||
| Standard Deviation | 8.11 | |||
| Variance | 65.78 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pure Bioscience
The number of cover stories for Pure Bioscience depends on current market conditions and Pure Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pure Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pure Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Other Information on Investing in Pure OTC Stock
Pure Bioscience financial ratios help investors to determine whether Pure OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pure with respect to the benefits of owning Pure Bioscience security.